Stamford, CT -- (SBWIRE) -- 10/22/2013 -- Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletter and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Here are some trending Stocks in focus: China Ming Yang Wind Power Group Ltd(NYSE:MY), Novavax, Inc.(NASDAQ:NVAX), Janus Capital Group Inc(NYSE:JNS), VIVUS, Inc.(NASDAQ:VVUS)
China Ming Yang Wind Power Group Ltd(NYSE:MY) stock is at $3.22, down -4.17 percent from its previous close of $3.36. The stock opened the session at $3.39 and touched its highest price point at $3.48. China Ming Yang Wind Power stock’s lowest price point for the session stood at $3.21. Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive 100% during the previous three months trade. Its total trading volume is 2.11 million shares for the day, in comparison to its average trading volume of 2.07 million shares. China Ming Yang Wind Power Group Limited engages in designing, manufacturing, selling, leasing, and servicing megawatt-class, grid-connected, and horizontal-axis wind turbines primarily in the Peoples Republic of China.
Has MY Found The Bottom and Ready To Move Up? Find Out Here
Novavax, Inc.(NASDAQ:NVAX) stock is at $2.91, down -2.02 percent from its previous close of $2.94. Its today’s volume is 2.05 million shares, in comparison to its average trading volume of 3.05 million shares. The stock opened the session at $2.99 and touched its highest price point at $2.99. Novavax’s lowest price point for the session stood at $2.86 and its 52 week price range stood at $1.52 - $3.50. The company has a total of 152.72 million outstanding shares and its total market capitalization is $444.41 million. Its beta value stands at 2.17 times and earnings per share was $-0.26. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Has NVAX Found The Bottom And Ready To Gain Momentum? Find Out Here
Janus Capital Group Inc(NYSE:JNS) opened the session at $9.46 and remained in the $9.36 to $9.56 price range during the session. The stock is -0.95 percent lower at $9.37. Volume closed the day at 2.02 million shares, its average volume being 2.16 million shares. The company has a total of 189.49 million outstanding shares and its total market capitalization is $1.78 billion. Its beta value stands at 2.74 times and earnings per share was $0.54. JNS was a gainer in the 5 days activity and jumped about 2.85%. The one month performance of the stock was positive and it scored more than 6.6%. Janus Capital Group, Inc. is a publicly owned asset management holding company with approximately $167.7 billion in assets under management.
Why Should Investors Buy JNS After the Recent Fall? Just Go Here and Find Out
VIVUS, Inc.(NASDAQ:VVUS)traded in the range of $9.40 and $9.88 in its previous trading session. The stock recorded the volume of 2.02 million shares, in comparison to its average daily trading volume of 3.15 million shares. Company’s year to date performance remained declining as it lost almost -28.01%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -20.28%. The stock opened at $9.76 and its closing price for the day was $9.51, down -2.86 percent from its previous close of $9.79. VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health
Will VVUS Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)